Stewart, D.J. (2008) Design of Phase II Cancer Trials Using a Continuous End Point of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 100, 445-446.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享